Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
Kleindorfer
Dawn O
DO
Khatri
Pooja
P
Katzan
Irene
I
D000208:Acute Disease / Q000628:therapy; D002545:Brain Ischemia / Q000188:drug therapy*; D004632:Emergency Medical Services / Q000592:standards / Q000706:statistics & numerical data; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000592:standards / Q000706:statistics & numerical data*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D028761:Withholding Treatment
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator